Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Budesonide vs Placebo on Lower Leg Growth in Children with Asthma
NCT00092092Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2002
- Primary completion
- Jun 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of montelukast in asthma (4 arms), sponsored by Organon & Co. Primary endpoint: Short-term lower-leg growth rate at 3 weeks. Started Oct 2002; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00092092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092092.